Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2025-12-25 @ 2:40 AM
NCT ID:
NCT01112033
Eligibility Criteria:
Inclusion Criteria:
BLVRA expression study
* Therapeutically naïve HCV patients undergoing antiviral treatment with peg-interferon plus ribavirin combination therapy
BLVRA genetic polymorphisms study
* HCV infected patients prior, during, after or without antiviral therapy
Exclusion Criteria:
* Co-infection with HAV, HBV and HIV
* Disorders of heme metabolism
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT01112033
Study Brief:
Protocol Section:
NCT01112033